Delivery Order SPE2DB24D2003-SPE2DB25FXNC1
Award Date 9/23/25
Potential Completion Date 9/24/25
Potential Value $3.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,149.65 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 mL auto-injector units on September 5, 2025, with a completion date of September 8, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), an enterprise-wide pharmaceutical prime vendor vehicle valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,062.43 to AmerisourceBergen Drug Corp for the supply of XYOSTED 50 mg/0.5 ml auto-injector units. The contract is a firm fixed price delivery order with an ultimate completion date of August 22, 2025, awarded on August 21, 2025, with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,936.96 delivery order on July 23, 2025, for XYOSTED 75 mg/0.5 mL auto-injector units (0.5 mL). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 24, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under the company's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $3,403.64 to AmerisourceBergen Drug Corp for XYOSTED 100 mg/0.5 mL auto-injector vials on August 6, 2025, with completion scheduled for August 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. XYOSTED is a testosterone replacement therapy product, reflecting the company's role in...
- The Defense Logistics Agency awarded a delivery order valued at $1,204.42 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 ml auto-injector units on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. XYOSTED is a testosterone replacement therapy medication delivered via auto-injector,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 ml auto-injector supplies, valued at $1,006.78 under a firm fixed-price arrangement. The award, issued on June 30, 2025, with an ultimate completion date of July 1, 2025, represents a non-competitive delivery order. Performance will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,253.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XYOSTED 100 mg/0.5 mL auto-injector units. The contract, issued on September 19, 2025, with completion targeted for September 22, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX). This IDC, valued at $999.999 billion through December 2026, serves as a comprehensive global pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $3,816.88 to AmerisourceBergen Drug Corp for XYOSTED 100 MG/0.5 ML auto-injector supplies. This non-set-aside, firm fixed-price delivery order was executed on August 12, 2025, with an ultimate completion date of August 13, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. XYOSTED is a testosterone replacement therapy product used in the treatment of hormone deficiency, representing part of the...
- The Defense Logistics Agency awarded a delivery order valued at $9,864.56 to AmerisourceBergen Drug Corp for XYOSTED 100 mg/0.5 ml auto-injector supplies. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by August 11, 2025. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. XYOSTED is a testosterone replacement therapy product delivered via auto-injector, supporting the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $3,706.98 to AmerisourceBergen Drug Corp for XYOSTED 100 mg/0.5 mL auto-injector supplies on September 10, 2025, with completion targeted for September 11, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. XYOSTED is a testosterone replacement therapy product delivered via...